Kapadi
Oscar
Maverick Trading
Major Players | B Corp
Maverick Trading
Maverick Trading
Connect with headhunters to apply for similar jobsMajor Players | B Corp
OCPA
OCPA
Digital Silk - Growing Brands Online
AG Talent
Athsai
AG Talent
Digital Silk - Growing Brands Online
Touchstone Advisory Limited
RHR UK
Netbox Recruitment
Touchstone Advisory Limited
A clinical research organization is seeking a highly-motivated Clinical Research Associate II - Study Start-Up and Maintenance. This home-based position will involve overseeing study startup and regulatory activities for Phase I-IV clinical trials, ensuring compliance with protocols and applicable regulations. Applicants should have at least 5 years of experience in study start-up roles, with a strong background in clinical research and development, ideally in oncology. Strong organizational and mentoring skills are also desirable.
Kapadi is a full service CRO that focuses on complex oncology indications including immunotherapy and cellular therapies. We know that innovative research requires innovative operations and we've built that into our culture, systems and processes. We have an infrastructure to enhance access to patients and integrated technology to provide higher quality and faster access to results. We are looking for a highly-motivated Clinical Research Associate II - Study Start-Up and Maintenance to help us continue to grow our business and deliver new, life-changing therapies for the cancer patients who need them.
As a Clinical Research Associate II - Study Start-Up and Maintenance, you will:
Candidates who also bring in experience in compiling EU CTR submissions via CTIS in Ireland or even other EU CTR countries and with additional language skills are preferred. This position is homebased!
* The salary benchmark is based on the target salaries of market leaders in their relevant sectors. It is intended to serve as a guide to help Premium Members assess open positions and to help in salary negotiations. The salary benchmark is not provided directly by the company, which could be significantly higher or lower.